What do families think about genetic testing? new study seeks answers
NCT ID NCT02814747
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study from France involved 530 families of children with rare developmental disorders. Researchers used surveys and interviews to understand how families feel about high-throughput genetic sequencing, including unexpected findings. The goal is to improve how doctors inform and obtain consent from families before using these advanced genetic tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors better explain genetic tests to families and improve how consent is obtained for advanced sequencing.
- What could go wrong
- This is an observational study, not a treatment trial. It gathers opinions and experiences, so it won't directly change medical care or outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RARE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One-shot gene editor aims to correct a brain disorder at its source
- Hackathon for the undiagnosed: mayo clinic launches repository to crack rare disease cases
- Biobank aims to unlock genetic secrets of rare diseases
- AI could shorten the long road to a rare disease diagnosis
- New hope for kids with MVID: drug aims to cut diarrhea and IV needs
- Scientists launch study to map rare baker gordon syndrome from childhood to adulthood